Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret
It’s not often that a company with the scale and…
Sell
29
SBT Quote, Financials, Valuation and Earnings
Last price:
$4.76
Seasonality move
:
0.21%
Day range:
$4.71 - $4.78
52-week range:
$4.40 - $5.97
Dividend yield:
0%
P/E ratio:
38.60x
P/S ratio:
4.10x
P/B ratio:
0.73x
Volume:
72.7K
Avg. volume:
31.1K
1-year change:
-17.22%
Market cap:
$243.1M
Revenue:
$67.7M
EPS (TTM):
$0.12
| Period Ending | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $132.4M | $110.1M | $95.6M | $80.1M | $67.7M | |
| Revenue Growth (YoY) | -6.83% | -16.86% | -13.2% | -16.14% | -15.48% | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $29.9M | $32.4M | $30.2M | $34.7M | $37M | |
| Other Inc / (Exp) | $120K | $287K | $1.3M | -$548K | -$52K | |
| Operating Expenses | $29.9M | $32.4M | $31.7M | $34.7M | $37M | |
| Operating Income | -- | -- | -- | -- | -- | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | $44.9M | -$18.9M | $33M | -$7.6M | $10.6M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $15.6M | -$5.9M | $9.6M | $6.6M | $3.1M | |
| Net Income to Company | $29.2M | -$13M | $23.4M | -$14.2M | $7.4M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $29.2M | -$13M | $23.4M | -$14.2M | $7.4M | |
| Basic EPS (Cont. Ops) | $0.57 | -$0.26 | $0.47 | -$0.28 | $0.15 | |
| Diluted EPS (Cont. Ops) | $0.57 | -$0.26 | $0.47 | -$0.28 | $0.15 | |
| Weighted Average Basic Share | $51.1M | $49.8M | $50M | $50.3M | $50.6M | |
| Weighted Average Diluted Share | $51.1M | $49.8M | $50.1M | $50.3M | $50.8M | |
| EBITDA | -- | -- | -- | -- | -- | |
| EBIT | $99.3M | $26.7M | $58.4M | $13.6M | $72.4M | |
| Revenue (Reported) | $132.4M | $110.1M | $95.6M | $80.1M | $67.7M | |
| Operating Income (Reported) | -- | -- | -- | -- | -- | |
| Operating Income (Adjusted) | $99.3M | $26.7M | $58.4M | $13.6M | $72.4M | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Revenue | $26.8M | $23.3M | $19.2M | $16.4M | $14M | |
| Revenue Growth (YoY) | -19.17% | -13.19% | -17.6% | -14.62% | -14.54% | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $8.5M | $3.2M | $9.7M | $9M | $8.8M | |
| Other Inc / (Exp) | -$20K | $1.4M | -$184K | -$137K | $160K | |
| Operating Expenses | $8.5M | $4.6M | $9.7M | $9M | $8.8M | |
| Operating Income | -- | -- | -- | -- | -- | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | -$281K | $13.2M | $1.9M | $618K | $725K | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -$170K | $3.7M | $742K | $304K | $868K | |
| Net Income to Company | -$111K | $9.6M | $1.2M | $314K | -$143K | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -$111K | $9.6M | $1.2M | $314K | -$143K | |
| Basic EPS (Cont. Ops) | -$0.00 | $0.19 | $0.02 | $0.01 | -$0.00 | |
| Diluted EPS (Cont. Ops) | -$0.00 | $0.19 | $0.02 | $0.01 | -$0.00 | |
| Weighted Average Basic Share | $49.8M | $50.2M | $50.4M | $50.7M | $51.1M | |
| Weighted Average Diluted Share | $49.8M | $50.3M | $50.6M | $51.1M | $51.1M | |
| EBITDA | -- | -- | -- | -- | -- | |
| EBIT | $11M | $18.6M | $7.2M | $17.5M | $21.5M | |
| Revenue (Reported) | $26.8M | $23.3M | $19.2M | $16.4M | $14M | |
| Operating Income (Reported) | -- | -- | -- | -- | -- | |
| Operating Income (Adjusted) | $11M | $18.6M | $7.2M | $17.5M | $21.5M | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Revenue | $116.7M | $96M | $86.7M | $71.2M | $59.3M | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $29.3M | $30.5M | $34.9M | $37.3M | $34.7M | |
| Other Inc / (Exp) | $286K | $1.3M | -$633K | -$97K | $181K | |
| Operating Expenses | $29.3M | $32M | $34.9M | $37.3M | $34.7M | |
| Operating Income | -- | -- | -- | -- | -- | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | -$17.7M | $4.8M | $22.1M | -$14.4M | $9.2M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -$2.6M | $1.2M | $9.8M | $1.6M | $3.2M | |
| Net Income to Company | -$15M | $3.6M | $12.3M | -$16.1M | $6M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -$15M | $3.6M | $12.3M | -$16.1M | $6M | |
| Basic EPS (Cont. Ops) | $0.26 | $0.08 | $0.18 | $0.05 | $0.12 | |
| Diluted EPS (Cont. Ops) | $0.26 | $0.08 | $0.18 | $0.05 | $0.12 | |
| Weighted Average Basic Share | -- | -- | -- | -- | -- | |
| Weighted Average Diluted Share | -- | -- | -- | -- | -- | |
| EBITDA | -- | -- | -- | -- | -- | |
| EBIT | $30.9M | $36.2M | $38.7M | $38.3M | $85.6M | |
| Revenue (Reported) | $116.7M | $96M | $86.7M | $71.2M | $59.3M | |
| Operating Income (Reported) | -- | -- | -- | -- | -- | |
| Operating Income (Adjusted) | $30.9M | $36.2M | $38.7M | $38.3M | $85.6M | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Revenue | $84.4M | $70.3M | $61.4M | $52.4M | $43.9M | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $23.1M | $20.9M | $25.6M | $28.2M | $26M | |
| Other Inc / (Exp) | $302K | $1.3M | -$590K | -$139K | $94K | |
| Operating Expenses | $23.1M | $22.4M | $25.6M | $28.2M | $26M | |
| Operating Income | -- | -- | -- | -- | -- | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | -$2.2M | $21.5M | $10.6M | $3.7M | $2.4M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -$897K | $6.2M | $6.4M | $1.4M | $1.4M | |
| Net Income to Company | -$1.3M | $15.3M | $4.2M | $2.4M | $976K | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -$1.3M | $15.3M | $4.2M | $2.4M | $976K | |
| Basic EPS (Cont. Ops) | -$0.02 | $0.31 | $0.08 | $0.05 | $0.02 | |
| Diluted EPS (Cont. Ops) | -$0.02 | $0.31 | $0.08 | $0.05 | $0.02 | |
| Weighted Average Basic Share | $149.5M | $150M | $151M | $151.8M | $152.8M | |
| Weighted Average Diluted Share | $149.5M | $150.2M | $151.4M | $152.3M | $153.3M | |
| EBITDA | -- | -- | -- | -- | -- | |
| EBIT | $33.1M | $42.6M | $23M | $47.7M | $60.9M | |
| Revenue (Reported) | $84.4M | $70.3M | $61.4M | $52.4M | $43.9M | |
| Operating Income (Reported) | -- | -- | -- | -- | -- | |
| Operating Income (Adjusted) | $33.1M | $42.6M | $23M | $47.7M | $60.9M | |
| Period Ending | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $78.8M | $1B | $412.9M | $380.7M | $583.2M | |
| Short Term Investments | -- | -- | -- | $343.6M | $419.2M | |
| Accounts Receivable, Net | $13.7M | $11M | $7.7M | $7.8M | $8.5M | |
| Inventory | -- | -- | -- | -- | -- | |
| Prepaid Expenses | -- | -- | -- | -- | -- | |
| Other Current Assets | -- | -- | -- | -- | -- | |
| Total Current Assets | $92.6M | $1B | $420.6M | $732.1M | $1B | |
| Property Plant And Equipment | $27.9M | $27.7M | $25.6M | $21.1M | $16.9M | |
| Long-Term Investments | $152.5M | $305M | $313.9M | $348.2M | $423.9M | |
| Goodwill | -- | -- | -- | -- | -- | |
| Other Intangibles | $9.8M | $5.7M | $2.7M | $1.8M | $1.5M | |
| Other Long-Term Assets | -- | -- | -- | -- | -- | |
| Total Assets | $3.2B | $3.9B | $2.9B | $2.4B | $2.4B | |
| Accounts Payable | -- | -- | -- | -- | -- | |
| Accrued Expenses | -- | -- | -- | -- | -- | |
| Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
| Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
| Other Current Liabilities | -- | -- | -- | -- | -- | |
| Total Current Liabilities | -- | -- | -- | -- | -- | |
| Long-Term Debt | $294.2M | $383.3M | $215.3M | $115.3M | $50M | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $2.9B | $3.6B | $2.5B | $2.1B | $2.1B | |
| Common Stock | $80.9M | $80.8M | $82.2M | $83.3M | $84.3M | |
| Other Common Equity Adj | -- | -- | -- | -- | -- | |
| Common Equity | $332.6M | $319.6M | $343.6M | $312.6M | $327.7M | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | $332.6M | $319.6M | $343.6M | $312.6M | $327.7M | |
| Total Liabilities and Equity | $3.2B | $3.9B | $2.9B | $2.4B | $2.4B | |
| Cash and Short Terms | $78.8M | $1B | $412.9M | $724.3M | $1B | |
| Total Debt | $294.2M | $383.3M | $215.3M | $115.3M | $50M | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $926M | $610.2M | $353.6M | $564.8M | $715.4M | |
| Short Term Investments | $247.9M | -- | -- | $398.3M | $436.4M | |
| Accounts Receivable, Net | $12.4M | $8.4M | $7.1M | $8.9M | $9.7M | |
| Inventory | -- | -- | -- | -- | -- | |
| Prepaid Expenses | -- | -- | -- | -- | -- | |
| Other Current Assets | -- | -- | -- | -- | -- | |
| Total Current Assets | $1.2B | $618.6M | $360.6M | $972M | $1.2B | |
| Property Plant And Equipment | $27.7M | $27.8M | $22.1M | $17.8M | $15.5M | |
| Long-Term Investments | $247.9M | $204.7M | $353.2M | $402.8M | $441.2M | |
| Goodwill | -- | -- | -- | -- | -- | |
| Other Intangibles | $6.4M | $2.9M | $1.8M | $1.6M | $1.3M | |
| Other Long-Term Assets | -- | -- | -- | -- | -- | |
| Total Assets | $3.9B | $3.1B | $2.4B | $2.4B | $2.4B | |
| Accounts Payable | -- | -- | -- | -- | -- | |
| Accrued Expenses | -- | -- | -- | -- | -- | |
| Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
| Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
| Other Current Liabilities | -- | -- | -- | -- | -- | |
| Total Current Liabilities | -- | -- | -- | -- | -- | |
| Long-Term Debt | $383.3M | $372.4M | $115.3M | $50M | -- | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $3.6B | $2.8B | $2.1B | $2.1B | $2.1B | |
| Common Stock | $80.8M | $82.2M | $83.3M | $84.3M | $84.3M | |
| Other Common Equity Adj | -- | -- | -- | -- | -- | |
| Common Equity | -- | -- | -- | -- | -- | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | $331.1M | $336.6M | $329.6M | $316.1M | $334.6M | |
| Total Liabilities and Equity | $3.9B | $3.1B | $2.4B | $2.4B | $2.4B | |
| Cash and Short Terms | $1.2B | $610.2M | $353.6M | $963.1M | $1.2B | |
| Total Debt | $383.3M | $372.4M | $115.3M | $50M | -- | |
| Period Ending | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $29.2M | -$13M | $23.4M | -$14.2M | $7.4M | |
| Depreciation & Amoritzation | $1.6M | $1.6M | $1.8M | $1.5M | $1.3M | |
| Stock-Based Compensation | $497K | $334K | $626K | $900K | $2.1M | |
| Change in Accounts Receivable | -$189K | $2.7M | $3.3M | -$133K | -$680K | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $60.8M | $8.6M | $30.7M | $2.3M | -$24.9M | |
| Capital Expenditures | $1.3M | $922K | $1.2M | $421K | $472K | |
| Cash Acquisitions | -- | -- | -$63.5M | -- | -- | |
| Cash From Investing | $7.6M | $223.8M | $352.5M | $373.7M | $238.4M | |
| Dividends Paid (Ex Special Dividend) | -$2M | -$499K | -- | -- | -- | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | $2.5B | $100M | -- | $35M | -- | |
| Long-Term Debt Repaid | -$2.5B | -$11M | -$168M | -$135M | -$65M | |
| Repurchase of Common Stock | -$30.3M | -$82K | -- | -- | -- | |
| Other Financing Activities | -- | -- | -$46K | -$216K | -$245K | |
| Cash From Financing | -$43.1M | $688.2M | -$970M | -$407.9M | -$15.3M | |
| Beginning Cash (CF) | $52.5M | $77.8M | $998.5M | $411.7M | $379.8M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $25.3M | $920.7M | -$586.8M | -$31.9M | $198.2M | |
| Ending Cash (CF) | $77.8M | $998.5M | $411.7M | $379.8M | $578M | |
| Levered Free Cash Flow | $59.5M | $7.7M | $29.6M | $1.9M | -$25.4M | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$111K | $9.6M | $1.2M | $314K | -$143K | |
| Depreciation & Amoritzation | $398K | $582K | $375K | $338K | $254K | |
| Stock-Based Compensation | $58K | $196K | $255K | $786K | $850K | |
| Change in Accounts Receivable | $1.5M | $1.3M | -$340K | -$1.4M | -$815K | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $1.6M | $16.5M | $1.9M | -$24.9M | $2.7M | |
| Capital Expenditures | $42K | $549K | $112K | $72K | -- | |
| Cash Acquisitions | -- | -$63.5M | -- | -- | -- | |
| Cash From Investing | $99M | $44.7M | $118.6M | -$1.1M | $54.4M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | -- | $35M | -- | -- | |
| Long-Term Debt Repaid | -$11M | -$11M | -$35M | -$65M | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -- | -- | -$8K | -$2K | -$232K | |
| Cash From Financing | $194M | -$226.3M | -$53.2M | -$65.8M | $53.5M | |
| Beginning Cash (CF) | $623.4M | $774.5M | $285.2M | $655.4M | $599.8M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $294.6M | -$165.1M | $67.2M | -$91.8M | $110.6M | |
| Ending Cash (CF) | $918M | $609.4M | $352.4M | $563.6M | $710.4M | |
| Levered Free Cash Flow | $1.6M | $15.9M | $1.8M | -$25M | $2.7M | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$15M | $3.6M | $12.3M | -$16.1M | $6M | |
| Depreciation & Amoritzation | $1.3M | $1.8M | $1.5M | $1.4M | $1.1M | |
| Stock-Based Compensation | $248K | $652K | $772K | $1.6M | $3.2M | |
| Change in Accounts Receivable | $1.5M | $4M | $1.3M | -$1.8M | -$796K | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $2.3M | $29.3M | $2.3M | -$29.6M | $1.5M | |
| Capital Expenditures | $717K | $2.7M | -$824K | $421K | $223K | |
| Cash Acquisitions | -- | -$63.5M | -- | -- | -- | |
| Cash From Investing | $150.4M | $390.5M | $395.1M | $216.4M | $169.6M | |
| Dividends Paid (Ex Special Dividend) | -$998K | -- | -- | -- | -- | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | $115M | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
| Repurchase of Common Stock | -$4.7M | -- | -- | -- | -- | |
| Other Financing Activities | -- | -- | -$204K | -$247K | -$836K | |
| Cash From Financing | $619M | -$728.4M | -$654.4M | $24.4M | -$24.3M | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $771.8M | -$308.6M | -$257M | $211.2M | $146.8M | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | $1.6M | $26.6M | $3.1M | -$30M | $1.3M | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$1.3M | $15.3M | $4.2M | $2.4M | $976K | |
| Depreciation & Amoritzation | $1.2M | $1.4M | $1.2M | $1M | $790K | |
| Stock-Based Compensation | $176K | $494K | $640K | $1.3M | $2.4M | |
| Change in Accounts Receivable | $1.3M | $2.6M | $635K | -$1M | -$1.1M | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $15.3M | $36M | $7.5M | -$24.4M | $2M | |
| Capital Expenditures | $494K | $2.3M | $326K | $326K | $77K | |
| Cash Acquisitions | -- | -$63.5M | -- | -- | -- | |
| Cash From Investing | $134.8M | $301.5M | $344.1M | $186.8M | $118M | |
| Dividends Paid (Ex Special Dividend) | -$499K | -- | -- | -- | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | $100M | -- | $35M | -- | -- | |
| Long-Term Debt Repaid | -$11M | -$11M | -$135M | -$65M | -$50M | |
| Repurchase of Common Stock | -$82K | -- | -- | -- | -- | |
| Other Financing Activities | -- | -$46K | -$204K | -$235K | -$826K | |
| Cash From Financing | $690M | -$726.6M | -$410.9M | $21.4M | $12.4M | |
| Beginning Cash (CF) | $1.1B | $2.6B | $1.2B | $1.5B | $1.8B | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $840.2M | -$389.1M | -$59.3M | $183.8M | $132.4M | |
| Ending Cash (CF) | $1.9B | $2.3B | $1.1B | $1.6B | $2B | |
| Levered Free Cash Flow | $14.8M | $33.7M | $7.2M | -$24.7M | $1.9M | |
Get SBT Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
SBT
Sector
P/E ratio
38.60x
12.02x
PEG ratio
0.23x
0.36x
P/B ratio
0.73x
1.05x
Price / LTM sales
4.10x
2.55x
Growth Metrics
SBT
Sector
Revenue growth
-14.54%
6.08%
Earnings growth
-40%
6.45%
Revenue (5-year growth)
-13.78%
5.85%
Earnings forecast
$0.03
$0.56
Profitability
SBT
Sector
Profitability FY 2024
--
$179.9M
Return on invested capital
1.69%
5.27%
Return on assets
0.25%
0.98%
Return on equity
1.85%
9.43%
Earnings Date
Last Earnings Date
Oct
30
Next Earnings Date
Jan
24
Estimated Next Earnings Date
Jan
29
Balance Sheet
SBT
Sector
Total cash
$1.2B
$617M
Short term investments
$419.2M
$408.4M
Total assets
$2.4B
$4.5B
Long term debt
--
$270.8M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will Tyson Foods Stock Bounce Back?
Tyson Foods, Inc. (NYSE:TSN) is one of the biggest food…
Will Iovance Biotherapeutics Stock Bounce Back?
Iovance Biotherapeutics (NASDAQ:IOVA) is a fledgling pharmaceutical company that specializes…
Stock Ideas
Buy
64
Is AAPL Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 42x
Buy
52
Is NVDA Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 113x
Buy
55
Is MSFT Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 37x
Alerts
Buy
61
QMCO alert for Dec 23
Quantum [QMCO] is up 9.73% over the past day.
Sell
46
NUKK alert for Dec 23
Nukkleus [NUKK] is up 13.45% over the past day.
Sell
1
IIPR alert for Dec 23
Innovative Industrial Properties [IIPR] is down 2.28% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
